HomeBWAY • NASDAQ
Brainsway Ltd - ADR
$9.40
Jan 13, 12:31:08 AM GMT-5 · USD · NASDAQ · Disclaimer
US listed securityIL headquartered
Previous close
$9.62
Day range
$9.21 - $9.49
Year range
$4.61 - $10.98
Market cap
178.10M USD
Avg Volume
57.12K
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
10.50M26.50%
Operating expense
7.44M18.02%
Net income
662.00K387.83%
Net profit margin
6.30327.44%
Earnings per share
——
EBITDA
729.00K266.33%
Effective tax rate
10.18%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
48.13M8.97%
Total assets
72.10M20.62%
Total liabilities
28.07M51.28%
Total equity
44.03M—
Shares outstanding
33.10M—
Price to book
7.23—
Return on assets
1.02%—
Return on capital
1.61%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
662.00K387.83%
Cash from operations
2.28M67.99%
Cash from investing
-1.33M-163.64%
Cash from financing
-698.00K-1,146.43%
Net change in cash
263.00K-63.72%
Free cash flow
235.88K-68.54%
About
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
Founded
2003
Employees
134
Search
Clear search
Close search
Google apps
Main menu